Preventing Parkinson's pathology

DMM Disease Models and Mechanisms

Volumn 3, Issue 7-8, 2010, Pages 399-400

  DeSantis, Morgan E ^a   Dersh, Devin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; MOLECULAR LIBRARY;

CLINICAL FEATURE; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE DUPLICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LEWY BODY; NOTE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CAENORHABDITIS ELEGANS; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOLECULAR LIBRARY; PATHOLOGY; PHARMACOLOGY; PROTEIN QUATERNARY STRUCTURE; RAT; SACCHAROMYCES CEREVISIAE; TOXICITY;

ALPHA-SYNUCLEIN; ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; HUMANS; PARKINSON DISEASE; PROTEIN STRUCTURE, QUATERNARY; RATS; SACCHAROMYCES CEREVISIAE; SMALL MOLECULE LIBRARIES;

EID: 77954849892     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.005678     Document Type: Note

References (14)

1. Cao, S., Gelwix, C. C., Caldwell, K. A. and Caldwell, G. A. (2005). Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 3801-3812. (Pubitemid 40570413)
2. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F. et al. (2006). α-synuclein blocks ER-golgi traffic and Rab1 rescues neuron loss in parkinson's models. Science 313, 324-328. (Pubitemid 44480951)
3. Dawson, T. M. and Dawson, V. L. (2003). Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
4. Feany, M. B. and Bender, W. W. (2000). A Drosophila model of Parkinson's disease. Nature 404, 394-398.
5. Gitler, A. D. and Shorter, J. (2007). Prime time for alpha-synuclein. J. Neurosci. 27, 2433-2434.
6. Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J. C. et al. (2009). Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308-315.
7. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke, L. (2000). Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. (Pubitemid 30112148)
8. Outeiro, T. F. and Lindquist, S. (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772-1775.
9. Parkinson, J. (2002). An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci. 14, 223-236.
10. Parsons, A. B., Brost, R. L., Ding, H., Li, Z., Zhang, C., Sheikh, B., Brown, G. W., Kane, P. M., Hughes, T. R. and Boone, C. (2004). Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62-69.
11. Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C. H. et al. (2006). Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126, 611-625. (Pubitemid 44163601)
12. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J. et al. (2006). Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191.
13. Su, L. J., Auluck, P. K., Outeiro, T. F., Yeger-Lotem, E., Kritzer, J. A., Tardiff, D. F., Strathearn, K. E., Liu, F., Cao, S., Hamamichi, S. et al. (2009). Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis. Model. Mech. 3, 194-208.
14. van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M., Plasterk, R. H. and Nollen, E. A. (2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4, e1000027. (Pubitemid 351507866)